Dividend Growth Investing and chit chat. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Dividend Growth Investing and chit chat.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

Recommended by:

cal77

Jacob Marley

Menominee

To: Jacob Marley who wrote (1373)	12/5/2021 12:26:04 PM
From: chowder	3 Recommendations of 2146

Re: MRK vs AMGN Analysts seem to favor MRK a little more in the near term, there's not a lot of difference regarding ratings. It then comes down to whether you would prefer investing in pharmaceuticals or biotechnology. This is actually the first thing I look at, I call it what a company does for a living. Where I might avoid pharmaceuticals I wouldn't consider MRK but if I were looking to buy pharma I'd compare MRK to its peers and if had better numbers than its peers I'd own it. They both look good at this time at least from a ratings point of view.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next